A Small-Molecule Compound D6 Overcomes EGFR-T790M-Mediated Resistance in Non-Small Cell Lung Cancer

Researchers presented a small-molecule compound D6 which selectively inhibited tumor cell growth and migration in NSCLC cells with EGFR-TKI-resistant T790M-EGFR-activated mutations.